South Korean biopharmaceutical company EuBiologics (KOSDAQ:206650) secured a contract from UNICEF for the supply of oral cholera vaccines, according to a Friday filing with the Korea Exchange.
The contract, valued at 13.26 billion won, is valid until Aug. 3.
Shares of EuBiologics fell nearly 1% in recent trade.